SCHEMBL7708772

SCHEMBL7708772

COc1csc(-c2nc3cc(-c4cccc(F)c4)cc(N)n3n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
RAB9A P51151 2/20 0.38
PKM P14618 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
AMY1A P0DUB6 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP1B1 Q16678 1/20 0.36
F2RL3 Q96RI0 1/20 0.35
FYN P06241 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708546 0.89 NPC1 (0.42) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7705877 0.88 SMN1; SMN2 (0.41) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7711838 0.85 SMN1; SMN2 (0.50) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7711818 0.82 ALDH1A1 (0.42) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7709149 0.82 FYN (0.46) MAPTFYNPOLB
SCHEMBL7708503 0.78 NPC1 (0.53) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7703064 0.78 ALDH1A1 (0.45) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7433615 0.77 KDM4E (0.39) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7705875 0.77 TP53 (0.42) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD
SCHEMBL7703244 0.74 DPP4 (0.47) SMN1; SMN2KDM4ENPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed